The 29 references in paper M. Boldina V., L. Postnikova B., N. Kubysheva I., S. Soodaeva K., М. Болдина В., Л. Постникова Б., Н. Кубышева И., С. Соодаева К. (2014) “УЧАСТИЕ ПРОВОСПАЛИТЕЛЬНЫХ ЦИТОКИНОВ IL-17, IL-18 И TNF-A В РАЗВИТИИ НАРУШЕНИЙ ЛЕГОЧНОЙ И ВНУТРИСЕРДЕЧНОЙ ГЕМОДИНАМИКИ ПРИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ // A ROLE OF PROINFLAMMATORY CYTOKINES IL-17, IL-18 AND TNF-A IN PULMONARY AND INTRACARDIAC HAEMODINAMIC DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE” / spz:neicon:pulmonology:y:2014:i:1:p:32-37

1
Hogg J.C., Timens W.The pathology of chronic obstructive pulmonary disease. Ann. Rev. Pathol. 2009; 4: 435–459.
(check this in PDF content)
2
Thabut G., Dauriat G., Stern J.B. et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531–1536.
(check this in PDF content)
3
BarberàJ.A. Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension. Pulm. Circulat. 2013; 3 (1): 160–164.
(check this in PDF content)
4
GalièN., Hoeper M.M., Humbert M. et al.Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Рис. 7. Ассоциации содержания провоспалительных цитокинов и ОФВ1у больных ХОБЛ IL-18 rs= 0,05 IL-17 rs= –0,53 p< 0,001 ОФВ1 TNF-α rs= –0,37 p= 0,017 CрДЛА rs= –0,314 p= 0,043 Таблица 2 Корреляционные связи содержания IL-17, IL-18 и TNF-αкрови и показателей легочной и внутрисердечной гемодинамики ПоказательIL-17IL-18TNF-α СрДЛАrs= +0,84rs= +0,63 rs= +0,61 р< 0,001р< 0,001р< 0,001 Парастернальныйrs= +0,51rs= +0,4rs= +0,48 раз
(check this in PDF content)
5
Oswald-Mammosser M., Apprill M., Bachez P. et al.Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 1991; 58: 304–310.
(check this in PDF content)
6
Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic сharacterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.
(check this in PDF content)
7
Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.
(check this in PDF content)
8
Струтынский А.В., Бакаев Р.Г., Сивцева А.И. и др. Диагностика легочного сердца у больных с хронической обструктивной болезнью легких. Клин. мед. 2009; 2: 56–60.
(check this in PDF content)
9
Kessler R., Faller M., Weitzenblum E. et al. Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2001; 164: 219–224.
(check this in PDF content)
10
Рябова А.Ю.Особенности ремоделирования сердца у больных БА и ХОБЛ: Автореф. дис. ... д-ра мед. наук. СПб.; 2008.
(check this in PDF content)
11
Сивцева А.И.Формирование хронического легочного сердца и возможности медикаментозной коррекции процесса ремоделирования правых и левых отделов сердца у больных ХОБЛ: Автореф. дис. ... д-ра мед. наук. М.; 2009.
(check this in PDF content)
12
Fisher M., Forfia P., Chamera E. et al.Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am. J. Respir. Crit Care Med. 2009; 179: 615–621.
(check this in PDF content)
13
Moermans C., Heinen V., Nguyen M. et al. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine 2011; 56: 298–304.
(check this in PDF content)
14
Linden A., Laan M., Anderson G.P.Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 2005; 25:
(check this in PDF content)
15
172. 15.Di Stefano A., Caramori G., Gnemmi I. et al.T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin. Exp. Immunol. 2009; 157: 316–324.
(check this in PDF content)
16
Etsuko Kurimoto E., Miyahara N., Kanehiro A. et al.IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir. Res. 2013; 14: 5–14.
(check this in PDF content)
17
Якушенко Е.В., Лопатникова Ю.А., Сенников С.В. Интерлейкин-18 и его роль в иммунном ответе. Мед. иммунол. 2005; 7 (4): 355–364.
(check this in PDF content)
18
Kang M.-J., Choi J.-M., Kim B.H. et al.L-18 induces emphysema and airway and vascular remodeling via IFN-α, IL-17A, and IL-13. Am. J. Respir. Crit. Care Med. 2012; 85 (11): 1205–1217.
(check this in PDF content)
19
Larsen K.-O., Lygren B., Sjaastad I. et al.Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovasc. Res. 2008; 80 (1): 47–54.
(check this in PDF content)
20
Imaoka H., Hoshino T., Takei S. et al. Interleukin-18 production and pulmonary function in COPD. Eur. Respir. J. 2008; 31: 287–297.
(check this in PDF content)
21
Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. 2011: Пер. с англ. под ред. А.С.Белевского М.: РРО; 2012.
(check this in PDF content)
22
Kitabatake A., Inoue M., Asao M. et al.Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68 (2): 302–309.
(check this in PDF content)
23
Кузубова Н.А, Гичкин А.Ю., Суркова Е.А. и др.Роль системного воспаления и эндотелиальной дисфункции в развитии левожелудочковой недостаточности у больных хронической обструктивной болезнью легких. Пульмонология 2013; 4: 41–45.
(check this in PDF content)
24
Rudsski L.G., Lai W.W., Afilalo J. et al.Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23: 685–713.
(check this in PDF content)
25
Ivanov S., Linden A.New drugs and targets for asthma and COPD. Progr. Respir. Res. 2010; 39: 141–149.
(check this in PDF content)
26
Pridgeon С., Bugeon L., Donnelly L. et al. Regulation of IL-17 in chronic inflammation in the human lung. Clin. Sci. 2011; 120: 515–524.
(check this in PDF content)
27
Barnes P.J. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nature Rev. Drug Dis. 2013; 12: 543–559
(check this in PDF content)
28
Kawayama T., Okamoto M., Imaoka H. et al.Interleukin-18 in pulmonary inflammatory diseases. J. Interfer. Cyt. Res. 2012; 32 (10): 443–449.
(check this in PDF content)
29
Kamal D., Choubey M.D. Cytokines in autoimmunity: Role in induction, regulation and treatment. J. Interfer. Cyt. Res. 2011; 31 (10): 695–703. Информация об авторах Болдина Марина Викторовна – ассистент кафедры внутренних болез-
(check this in PDF content)